Morphosys AG - BioTech fighting cancer
✅✅✅✅✅ Morphosys is a global biotech company that develops and commercializes therapeutic antibodies for patients suffering from cancer and autoimmune diseases. They have over 100 drugs in its wider pipeline, with many partnerships with other pharma and biotech companies. The closing price today was at €71.04 , the 52-week high was €125.20, and the 52-week low at €71.62, this means we are almost spot on the low - may be a good opportunity? How has the development been in the last years... The 1-year and 3-year are down with respective -26% and -18% , while the 5-year and 10-year development is up with +66% and +258%! ✅ What does the 10-year chart look like Looks pretty good - I see a long upward trend which now almost is down and touches and the support level. A high peak at the end of 2019 at ~€125, not that long ago, and even the Corona crash is not that visible like in other companies A view on the holders' list shows that there is no majority holder (or strong o...